Bellevue Group Ag Moderna, Inc. Transaction History

Bellevue Group Ag

$5.98 Billion
Q2 2024

A detailed history of Bellevue Group Ag transactions in Moderna, Inc. stock. As of the latest transaction made, Bellevue Group Ag holds 1,563,735 shares of MRNA stock, worth $103 Million. This represents 3.11% of its overall portfolio holdings.

Number of Shares

1,563,735

Previous 1,711,089 8.61%

Holding current value

$103 Million

Previous $182 Million 1.84%

% of portfolio

3.11%

Previous 2.86%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $14.9 Million - $24.6 Million	-147,354 Reduced 8.61%	1,563,735 $186 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $16.8 Million - $22.8 Million	-197,331 Reduced 10.34%	1,711,089 $182 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $28.7 Million - $43.1 Million	413,095 Added 27.63%	1,908,420 $190 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $2.87 Million - $3.76 Million	-29,734 Reduced 1.95%	1,495,325 $154 Million
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $3.16 Million - $4.28 Million	-26,647 Reduced 1.72%	1,525,059 $185 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $4.15 Million - $6.03 Million	-30,622 Reduced 1.94%	1,551,706 $238 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $2.67 Million - $4.73 Million	22,527 Added 1.44%	1,582,328 $284 Million
Q3 2022 Nov 14, 2022	SELL	$118.07 - $194.18 $2.07 Million - $3.41 Million	-17,550 Reduced 1.11%	1,559,801 $184 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $7.26 Million - $10.9 Million	-61,998 Reduced 3.78%	1,577,351 $225 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $8.84 Million - $16.4 Million	-69,900 Reduced 4.09%	1,639,349 $282 Million
Q4 2021 Feb 10, 2022	SELL	$225.82 - $368.51 $4.09 Million - $6.67 Million	-18,100 Reduced 1.05%	1,709,249 $434 Million
Q3 2021 Nov 12, 2021	SELL	$221.9 - $484.47 $181 Million - $395 Million	-814,951 Reduced 32.06%	1,727,349 $665 Million
Q2 2021 Aug 12, 2021	SELL	$129.91 - $234.98 $34.8 Million - $62.9 Million	-267,650 Reduced 9.53%	2,542,300 $597 Million
Q1 2021 May 12, 2021	SELL	$109.18 - $185.98 $15 Million - $25.5 Million	-136,963 Reduced 4.65%	2,809,950 $368 Million
Q4 2020 Feb 16, 2021	SELL	$65.74 - $169.86 $26 Million - $67.1 Million	-395,037 Reduced 11.82%	2,946,913 $308 Million
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $163,020 - $284,550	-3,000 Reduced 0.09%	3,341,950 $236 Million
Q2 2020 Aug 13, 2020	SELL	$29.67 - $80.0 $18 Million - $48.4 Million	-605,231 Reduced 15.32%	3,344,950 $215 Million
Q1 2020 May 14, 2020	SELL	$17.78 - $31.58 $17.5 Million - $31.1 Million	-984,900 Reduced 19.96%	3,950,181 $118 Million
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $1.27 Million - $1.94 Million	91,000 Added 1.88%	4,935,081 $96.5 Million
Q3 2019 Nov 14, 2019	BUY	$12.26 - $18.07 $1.47 Million - $2.17 Million	119,835 Added 2.54%	4,844,081 $77.1 Million
Q2 2019 Aug 14, 2019	BUY	$13.7 - $28.34 $64.7 Million - $134 Million	4,724,246 New	4,724,246 $69.2 Million

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bellevue Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Bellevue Group Ag with notifications on news.

Account

Bellevue Group Ag Moderna, Inc. Transaction History